Canopy Growth Reports 7% YoY Increase In Q4 Net Revenue, Continues Focus On Innovation In Canada And International Expansion
Canopy Growth Reports 7% YoY Increase In Q4 Net Revenue, Continues Focus On Innovation In Canada And International Expansion
Canopy Growth報告第四季度淨收入同比增長7％，繼續關注加拿大的創新和國際擴張
Canopy Growth Corporation (TSX:WEED) (NASDAQ:CGC) announced its financial results on Thursday for the fourth quarter and fiscal year ended March 31, 2024.
Canopy Growth Corporation（多倫多證券交易所股票代碼：WEED）（納斯達克股票代碼：CGC）週四公佈了截至2024年3月31日的第四季度和財年的財務業績。
Fourth quarter net revenue for the company's subsidiary Storz & Bickel which manufactures high-end and medically certified cannabis vaporizers surged 43% year-over-year to CA$22million ($16 million).
該公司生產高端和經醫學認證的大麻蒸發器的子公司Storz & Bickel的第四季度淨收入同比增長43％，至2200萬加元（合1600萬美元）。
Canada's cannabis net revenue in the same period increased 4% year-over-year led by a 16% increase in the Canada medical cannabis business that saw its 5th consecutive quarter of revenue growth.
同期加拿大的大麻淨收入同比增長4％，這主要是加拿大醫用大麻業務增長16％，該業務連續第五個季度實現收入增長。
Canopy CEO David Klein said the company made "remarkable progress and delivered dramatic reductions in expenses, cash burn, and...
Canopy首席執行官戴維·克萊因表示...
登入免費觀看全文
登入/註冊